| Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production A Merovci, C Solis-Herrera, G Daniele, R Eldor, TV Fiorentino, D Tripathy, ... The Journal of clinical investigation 124 (2), 509-514, 2014 | 864 | 2014 |
| Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection L Montefusco, M Ben Nasr, F D’Addio, C Loretelli, A Rossi, I Pastore, ... Nature Metabolism 3 (6), 774-785, 2021 | 327 | 2021 |
| The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 … G Daniele, R Guardado Mendoza, D Winnier, TV Fiorentino, Z Pengou, ... Acta diabetologica 51, 123-131, 2014 | 312 | 2014 |
| Dapagliflozin enhances fat oxidation and ketone production in patients with type 2 diabetes G Daniele, J Xiong, C Solis-Herrera, A Merovci, R Eldor, D Tripathy, ... Diabetes care 39 (11), 2036-2041, 2016 | 203 | 2016 |
| Dapagliflozin lowers plasma glucose concentration and improves β-cell function A Merovci, A Mari, C Solis, J Xiong, G Daniele, A Chavez-Velazquez, ... The Journal of Clinical Endocrinology & Metabolism 100 (5), 1927-1932, 2015 | 198 | 2015 |
| Type 2 diabetes mellitus worsens arterial stiffness in hypertensive patients through endothelial dysfunction RM Bruno, G Penno, G Daniele, L Pucci, D Lucchesi, F Stea, L Landini, ... Diabetologia 55, 1847-1855, 2012 | 144 | 2012 |
| Sclerostin and insulin resistance in prediabetes: evidence of a cross talk between bone and glucose metabolism G Daniele, D Winnier, A Mari, J Bruder, M Fourcaudot, Z Pengou, ... Diabetes care 38 (8), 1509-1517, 2015 | 117 | 2015 |
| Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individuals G Daniele, R Eldor, A Merovci, GD Clarke, J Xiong, D Tripathy, ... Diabetes 63 (8), 2812-2820, 2014 | 101 | 2014 |
| Exenatide improves both hepatic and adipose tissue insulin resistance: a dynamic positron emission tomography study A Gastaldelli, M Gaggini, G Daniele, D Ciociaro, E Cersosimo, D Tripathy, ... Hepatology 64 (6), 2028-2037, 2016 | 96 | 2016 |
| Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3–TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic … D Tripathy, G Daniele, TV Fiorentino, Z Perez-Cadena, ... Diabetologia 56, 2153-2163, 2013 | 92 | 2013 |
| Ectopic fat: the true culprit linking obesity and cardiovascular disease? M Morelli, M Gaggini, G Daniele, P Marraccini, R Sicari, A Gastaldelli Thrombosis and haemostasis 110 (10), 651-660, 2013 | 83 | 2013 |
| Empagliflozin Treatment Is Associated With Improved β-Cell Function in Type 2 Diabetes Mellitus H Al Jobori, G Daniele, J Adams, E Cersosimo, C Solis-Herrera, C Triplitt, ... The Journal of Clinical Endocrinology & Metabolism 103 (4), 1402-1407, 2018 | 82 | 2018 |
| Determinants of the increase in ketone concentration during SGLT2 inhibition in NGT, IFG and T2DM patients H Al Jobori, G Daniele, J Adams, E Cersosimo, C Triplitt, RA DeFronzo, ... Diabetes, Obesity and Metabolism 19 (6), 809-813, 2017 | 79 | 2017 |
| Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus G Sesti, A Avogaro, S Belcastro, BM Bonora, M Croci, G Daniele, ... Acta diabetologica 56, 605-617, 2019 | 76 | 2019 |
| Empagliflozin and kinetics of renal glucose transport in healthy individuals and individuals with type 2 diabetes H Al-Jobori, G Daniele, E Cersosimo, C Triplitt, R Mehta, L Norton, ... Diabetes 66 (7), 1999-2006, 2017 | 72 | 2017 |
| Exenatide regulates cerebral glucose metabolism in brain areas associated with glucose homeostasis and reward system G Daniele, P Iozzo, M Molina-Carrion, J Lancaster, D Ciociaro, ... Diabetes 64 (10), 3406-3412, 2015 | 64 | 2015 |
| Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: a … M Garofolo, E Gualdani, R Giannarelli, M Aragona, F Campi, D Lucchesi, ... Cardiovascular diabetology 18, 1-16, 2019 | 61 | 2019 |
| Insulin resistance and endothelial dysfunction: a mutual relationship in cardiometabolic risk S Del Turco, M Gaggini, G Daniele, G Basta, F Folli, R Sicari, A Gastaldelli Current pharmaceutical design 19 (13), 2420-2431, 2013 | 56 | 2013 |
| Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus G Penno, E Russo, M Garofolo, G Daniele, D Lucchesi, L Giusti, ... Diabetologia 60, 1102-1113, 2017 | 50 | 2017 |
| Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity/mortality? Yes C Bianchi, R Miccoli, G Daniele, G Penno, S Del Prato Diabetes care 32 (Suppl 2), S342, 2009 | 49 | 2009 |
Del Prato StefanoUniversity of PisaDirección de correo verificada de med.unipi.it
